Dianthus Therapeutics | MGTA - Дебиторская задолженность





Дебиторская задолженность Изменить Дата
Akebia Therapeutics USD 47.03M 19.19M 2025-12
Alaunos Therapeutics USD 2K 0 2025-06
Avita Medical AUD 9.11M 2.26M 2025-12
Celltrion KRW 2.05T 542.39B 2025-12
Cspc Pharmaceutical CNY 8.79B 64.64M 2025-12
Deva Holding AS TRY 3.03B 343.23M 2023-09
Dianthus Therapeutics USD 52K 4.95M 2025-12
Divis Laboratories Ltd INR 29.99B 3.71B 2026-03
IQVIA Holdings USD 3.38B 52M 2026-03
Kangmei Pharma CNY 2.92B 228.09M 2026-03
Knight Therapeutics CAD 183M 7.46M 2025-12
Laboratorios Farma EUR 143.38M 16.93M 2023-12
Malin Corporation EUR 500K 300K 2024-12
Medical Developments International AUD 7.48M 174K 2025-12
Moderna USD 71M 113M 2026-03
Neuren Pharmaceuticals AUD 26.54M 5.83M 2025-12
Organigram Holdings CAD 49.94M 14.92M 2025-12
Organon & Co USD 1.33B 153M 2025-12
Ovoca Bio EUR 39K 408K 2025-06
Pharma Mar EUR 51.19M 9.4M 2026-03
Qiagen NV USD 402.61M 9.05M 2025-12
Revvity USD 691.38M 53.29M 2026-03
Sartorius EUR 366.6M 74.9M 2026-03
Sino Biopharmaceutical CNY 8.45B 3.18B 2025-06
Tectonic Therapeutic USD 0 270K 2023-12
Tilray USD 109.07M 2M 2025-09
Viatris USD 3.08B 45M 2026-03
Xeris Pharmaceuticals USD 51.05M 2.7M 2025-12
Zealand Pharma A/S 340M 94.1M 2025-12
Zz Pientze Pharmaceu CNY 1.06B 60.42M 2026-03